Por favor, use este identificador para citar o enlazar este ítem:
https://www.arca.fiocruz.br/handle/icict/42474
Tipo
ArtículoDerechos de autor
Acceso abierto
Colecciones
- IOC - Artigos de Periódicos [12791]
Metadatos
Mostrar el registro completo del ítem
HEPATITIS C VIRUS-SPECIFIC CD4+ T CELL PHENOTYPE AND FUNCTION IN DIFFERENT INFECTION OUTCOMES
Autor
Afiliación
Massachusetts General Hospital and Harvard Medical School, Boston. Gastrointestinal Unit. Boston, Massachusetts, USA.
Massachusetts General Hospital and Harvard Medical School, Boston. Gastrointestinal Unit. Boston, Massachusetts, USA.
Massachusetts General Hospital and Harvard Medical School, Boston. Gastrointestinal Unit. Boston, Massachusetts, USA / Massachusetts General Hospital and Harvard Medical School, Infectious Disease Division. Boston
Massachusetts General Hospital and Harvard Medical School, Boston. Gastrointestinal Unit, Boston, Massachusetts, USA..
Massachusetts General Hospital and Harvard Medical School, Boston. Gastrointestinal Unit. Boston, Massachusetts, USA.
Massachusetts General Hospital and Harvard Medical School, Boston. Gastrointestinal Unit. Boston, Massachusetts, USA.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Hepatites Virais. Rio de Janeiro, RJ, Brasil.
Massachusetts General Hospital and Harvard Medical School, Boston. Gastrointestinal Unit. Boston, Massachusetts, USA.
Laboratório Central de Sáud Pública Noel Nutels. Rio de Janeiro, RJ, Brasil.
Massachusetts General Hospital and Harvard Medical School, Boston. Gastrointestinal Unit. Boston, Massachusetts, USA.
Massachusetts General Hospital and Harvard Medical School, Infectious Disease Division. Boston
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Infecções Virais. Rio de Janeiro, RJ, Brasil.
Massachusetts General Hospital and Harvard Medical School, Boston. Gastrointestinal Unit. Boston, Massachusetts, USA.
Massachusetts General Hospital and Harvard Medical School, Boston. Gastrointestinal Unit. Boston, Massachusetts, USA.
Massachusetts General Hospital and Harvard Medical School, Boston. Gastrointestinal Unit. Boston, Massachusetts, USA / Massachusetts General Hospital and Harvard Medical School, Infectious Disease Division. Boston
Massachusetts General Hospital and Harvard Medical School, Boston. Gastrointestinal Unit, Boston, Massachusetts, USA..
Massachusetts General Hospital and Harvard Medical School, Boston. Gastrointestinal Unit. Boston, Massachusetts, USA.
Massachusetts General Hospital and Harvard Medical School, Boston. Gastrointestinal Unit. Boston, Massachusetts, USA.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Hepatites Virais. Rio de Janeiro, RJ, Brasil.
Massachusetts General Hospital and Harvard Medical School, Boston. Gastrointestinal Unit. Boston, Massachusetts, USA.
Laboratório Central de Sáud Pública Noel Nutels. Rio de Janeiro, RJ, Brasil.
Massachusetts General Hospital and Harvard Medical School, Boston. Gastrointestinal Unit. Boston, Massachusetts, USA.
Massachusetts General Hospital and Harvard Medical School, Infectious Disease Division. Boston
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Infecções Virais. Rio de Janeiro, RJ, Brasil.
Massachusetts General Hospital and Harvard Medical School, Boston. Gastrointestinal Unit. Boston, Massachusetts, USA.
Resumen en ingles
CD4+ T cell failure is a hallmark of chronic hepatitis C virus (HCV) infection. However, the mechanisms underlying the impairment and loss of virus-specific CD4+ T cells in persisting HCV infection remain unclear. Here we examined HCV-specific CD4+ T cells longitudinally during acute infection with different infection outcomes. We found that HCV-specific CD4+ T cells are characterized by expression of a narrower range of T cell inhibitory receptors compared with CD8+ T cells, with initially high expression levels of PD-1 and CTLA-4 that were associated with negative regulation of proliferation in all patients, irrespective of outcome. In addition, HCV-specific CD4+ T cells were phenotypically similar during early resolving and persistent infection and secreted similar levels of cytokines. However, upon viral control, CD4+ T cells quickly downregulated inhibitory receptors and differentiated into long-lived memory cells. In contrast, persisting viremia continued to drive T cell activation and PD-1 and CTLA-4 expression, and blocked T cell differentiation, until the cells quickly disappeared from the circulation. Our data support an important and physiological role for inhibitory receptor-mediated regulation of CD4+ T cells in early HCV infection, irrespective of outcome, with persistent HCV viremia leading to sustained upregulation of PD-1 and CTLA-4.
Compartir